Trial

BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA)

Study Director
Michael Hoelscher
Start Date
10 / 2019
Trial Phase
Phase I
Trial Status
study in development
Current Enrollment
Target Enrollment
77
Overview
Registry Link
Developer Associations
University of Munich
EDCTP
Compound Associations
BTZ-043